Biblio

Export 2543 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is S  [Clear All Filters]
Journal Article
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)., J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)., J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)., J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
B. Reisberg, Torossian, C., Shulman, M. B., Monteiro, I., Boksay, I., Golomb, J., Benarous, F. Guillo, Ulysse, A., Oo, T., Vedvyas, A., Rao, J. A., Marsh, K., Kluger, A., Sangha, J., Hassan, M., Alshalabi, M., Arain, F., Shaikh, N., Buj, M., Kenowsky, S., Masurkar, A. V., Rabin, L., Noroozian, M., Sánchez-Saudinós, M. A. Belén, Blesa, R., Auer, S., Zhang, Y., de Leon, M., Sadowski, M., Wisniewski, T., Gauthier, S., and Shao, Y., Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)., J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
M. Sun, Zhao, Y., Han, M., Zhang, B., Zhang, X., Zhang, Q., Lim, N. K. - H., Wang, W. - A., and De Huang, F. -, TTC7 and Hyccin Regulate Neuronal Aβ42 Accumulation and its Associated Neural Deficits in Aβ42-Expressing Drosophila., J Alzheimers Dis, vol. 65, no. 3, pp. 1001-1010, 2018.
I. Lejri, Grimm, A., Hallé, F., Abarghaz, M., Klein, C., Maitre, M., Schmitt, M., Bourguignon, J. - J., Mensah-Nyagan, A. Guy, Bihel, F., and Eckert, A., TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis., J Alzheimers Dis, vol. 72, no. 4, pp. 1045-1058, 2019.
M. Li, Liu, E., Zhou, Q., Li, S., Wang, X., Liu, Y., Wang, L., Sun, D., Ye, J., Gao, Y., Yang, X., Liu, J., Yang, Y., and Wang, J. - Z., TRPC1 Null Exacerbates Memory Deficit and Apoptosis Induced by Amyloid-β., J Alzheimers Dis, vol. 63, no. 2, pp. 761-772, 2018.
W. Wu, Lee, I., Spratt, H., Fang, X., and Bao, X., tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms., J Alzheimers Dis, vol. 79, no. 2, pp. 793-806, 2021.
R. Ravona-Springer, Schnaider-Beeri, M., and Goldbourt, U., Triceps and Subscapular Skinfold in Men Aged 40-65 and Dementia Prevalence 36 Years Later., J Alzheimers Dis, vol. 57, no. 3, pp. 873-883, 2017.
M. A. Beydoun, Gamaldo, A. A., Beydoun, H. A., Shaked, D., Zonderman, A. B., and Eid, S. M., Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample., J Alzheimers Dis, vol. 57, no. 3, pp. 813-824, 2017.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., TREM2 variants in Alzheimer's disease., N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., TREM2 variants in Alzheimer's disease., N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., TREM2 variants in Alzheimer's disease., N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
M. Stoiljkovic, Gutierrez, K. Otero, Kelley, C., Horvath, T. L., and Hajós, M., TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-β-Related Hippocampal Pathophysiology in Mice., J Alzheimers Dis, 2021.
T. Sao, Yoshino, Y., Yamazaki, K., Ozaki, Y., Mori, Y., Ochi, S., Yoshida, T., Mori, T., Iga, J. - I., and Ueno, S. - I., TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 4, pp. 1275-1284, 2018.
S. D. Portbury, Hare, D. J., Sgambelloni, C., Perronnes, K., Portbury, A. J., Finkelstein, D. I., and Adlard, P. A., Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 60, no. 2, pp. 549-560, 2017.
A. Subic, Cermakova, P., Religa, D., Han, S., von Euler, M., Kåreholt, I., Johnell, K., Fastbom, J., Bognandi, L., Winblad, B., Kramberger, M. G., Eriksdotter, M., and Garcia-Ptacek, S., Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry., J Alzheimers Dis, vol. 61, no. 3, pp. 1119-1128, 2018.
M. M. Mielke, Ransom, J. E., Mandrekar, J., Turcano, P., Savica, R., and Brown, A. W., Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population., J Alzheimers Dis, vol. 88, no. 3, pp. 1049-1059, 2022.
T. P. Nguyen, Schaffert, J., LoBue, C., Womack, K. B., Hart, J., and C Cullum, M., Traumatic Brain Injury and Age of Onset of Dementia with Lewy Bodies., J Alzheimers Dis, vol. 66, no. 2, pp. 717-723, 2018.
X. Li, Song, Y., Sanders, C. R., and Buxbaum, J. N., Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor., J Alzheimers Dis, vol. 52, no. 4, pp. 1263-75, 2016.
X. Li, Song, Y., Sanders, C. R., and Buxbaum, J. N., Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor., J Alzheimers Dis, vol. 52, no. 4, pp. 1263-75, 2016.

Pages